Latest Announcements

White Oak Capital Management Consultants LLP has acquired 4,820,335 shares of Computer Age Management Services Ltd, increasing its stake to 3.29%.

Sadhana Nitrochem Limited has received trading approval for 6,75,00,000 equity shares issued under a preferential issue, which will be listed on the NSE from September 25, 2026.

Sadhana Nitro Chem Ltd has received trading approval for 6,75,00,000 equity shares issued under a preferential issue from BSE and NSE, effective from September 25, 2026.

Sammaan Capital Limited has informed the Exchange about the allotment of secured, rated, listed, taxable, redeemable, fully paid-up non-convertible debentures on a private placement basis.

Sammaan Capital Ltd has allotted 75,000 secured, rated, listed, taxable, redeemable, fully paid-up non-convertible debentures on a private placement basis, aggregating to Rs. 750 Crores.

Capital Infra Trust has informed the Exchange regarding the allotment of 1,66,11,200 units of the Trust on a preferential basis at Rs. 75.25 per unit.

Arambhveer Limited has submitted a public announcement to BSE for an open offer to acquire up to 21,81,121 equity shares of Mapro Industries Ltd, representing 26.00% of the voting share capital, at ₹ 60.13 per share.

Bajaj Housing Finance Ltd has allotted 81,500 secured redeemable non-convertible debentures on a private placement basis, aggregating to Rs. 807.8233 crore. The debentures will be listed on the Wholesale Debt Market Segment of BSE Limited.

Bajaj Housing Finance Limited has informed the Exchange regarding allotment of 81,500 Non-Convertible Securities, aggregating to Rs. 807.8233 crore, on private placement basis.

Ikoma Technologies Ltd has withdrawn its In-Principle Application for a proposed Rights Issue and also withdrawn its proposed acquisition of M/s ICM Insurance Brokers Private Limited due to the withdrawal of the Rights Issue.

Ikoma Technologies Ltd has withdrawn its In-Principle Application for a proposed Rights Issue and also withdrawn its proposed acquisition of M/s ICM Insurance Brokers Private Limited due to the withdrawal of the Rights Issue.

Angel One Ltd has allotted 5,58,270 equity shares to eligible employees under the Angel Broking Employee Long Term Incentive Plan 2021, increasing the issued, subscribed, and paid-up capital to Rs. 91,45,94,776.

Kabra Extrusion Technik Limited has received in-principle approval from National Stock Exchange of India Limited and BSE Limited for the issue of 37,60,000 Equity Shares on a preferential basis to Promoters & Promoter Group and Non-Promoters Category on a private placement basis.

CLN Energy Ltd has received a disclosure under Regulation 29(1) of SEBI (SAST) Regulations, 2011, indicating a substantial acquisition of shares by Craft Emerging Market Fund PCC and others, resulting in a 7.66% stake in the company.

Kabra Extrusiontechnik Ltd has received in-principle approval from National Stock Exchange of India Limited and BSE Limited for the issue of equity shares on a preferential basis to promoters and non-promoters on a private placement basis.

Natco Pharma Ltd has announced the record date for its rights issue, set as Thursday, 1st October, 2026, to determine the shareholders eligible to receive the rights entitlements.

Natco Pharma Limited has announced the record date for its rights issue as October 1, 2026, as per Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Natco Pharma Limited has informed the Exchange about issue of securities on rights basis, with the Board of Directors approving the issuance of equity shares for an amount not exceeding ₹12,79,35,61,500/- by way of a rights issue to eligible equity shareholders.

Fischer Medical Ventures Limited has informed the Exchange regarding the outcome of its Board Meeting held on September 24, 2026, where the Board approved and took on record the rights issues by its wholly owned subsidiaries, Time Medical International Ventures (India) Private Limited, FlynnCare Health Innovations Private Limited, and FMV Global Innovation Pte. Ltd., and the Company's investment in the equity shares of these subsidiaries.

Natco Pharma Ltd has announced the outcome of its Board Meeting, where it has approved the issuance of equity shares through a rights issue to eligible equity shareholders. The rights issue will be for an amount not exceeding ₹12,79,35,61,500 and will be priced at ₹750 per rights equity share.